Cannabis Patents You Might Not Have Expected To See

With over half of the United States having legalized some form of cannabis, the race to file patent applications has been on a steep rise. Patent Forecast® has calculated a 305% increase in patent application filings and patents in the…

Big Pharma Wants In On Cannabis

2021 ended with huge news that Pfizer would be entering the medical cannabis market with a $6.7 billion acquisition of Arena Pharmaceuticals announced in December 2021.   Arena Pharmaceuticals researches and develops cannabinoid receptor…

Cannabis-Enhanced Simulations Could Help Treat Various Psychological Disorders

An interesting patent application was published in December 2021 teaching a therapy process for psychological disorders utilizing a cannabinoid composition and an augmented reality (AR) or virtual reality (VR) experience. U.S. Patent…

Why Some Investors Aren’t Lighting Up Cannabis

Investors share vastly different opinions on cannabis but it all stems from one fundamental fact - cannabis is still illegal under federal law. The implications are quite serious and do raise more than reasonable concerns, the first being…

This Inhaler Company Could be Big Tobacco’s Next Target for Acquisition

Philip Morris International took the world by surprise when it announced it would acquire Vectura Group, an inhaler technology and platform company, in September 2021. The main concern - what is Philip Morris going to do with a company…

Verano’s Strategic Position in Florida that Could Lead it to the Top

Verano Holdings, LLC got its humble start in Illinois, privately funded with $120 million and poised to strategically consolidate operating cannabis facilities in what will help it to become one of the US’s leading multi-state operators…

Lexaria Bioscience To Test Altria-Backed DehydraTECH™ on Animal Seizures

Lexaria Bioscience Corp. isn’t a stranger to Patent Forecast®. In fact, we’ve been watching Lexaria since the acquisition of PoViva Tea to leverage its patented DehydraTECH which improves the delivery of active pharmaceutical ingredients.…

You Aren’t Tripping – Oregon Legalized Psilocybin

Oregon voted in favor of legalizing medicinal psilocybin in 2020, otherwise known as magic mushrooms. Cities all around the US have begun decriminalizing psychedelics with Washington, D.C. being the latest to hop on board. Oregon is now…

MSOs Looking to Take on Trulieve, Florida Acquisitions and Establishment Imminent

Florida legalized medical cannabis in 2014, opening up the third most populous state to the green market. Florida’s billion dollar medical marijuana (MMJ) market is now the subject of contention from multi state operators (MSOs), all eager…

Here’s What the Latest Nicoventures Vape Patent Applications Tell Us

In late September 2021, Patent Forecast discussed Nicoventures’ current patent activity and what could be expected of the company in the cannabis space. On September 30, 2021, five more patent applications relating to vape devices were…

Is Nicoventures Ditching Cannabis Vape Devices?

British American Tobacco’s (BAT) tobacco-alternatives company Nicoventures had three vape patent applications publish in September 2021. In July 2019, Nicoventures began its pursuit of cannabis patents for vape devices but quickly shifted…

Purissima is Securing Microalgal Cannabinoid Biosynthesis

Biosynthesis of cannabinoids has been a focal point of the cannabis industry the last 5 years. Leaders like Teewinot Life Sciences and CB Therapeutics emerged with scalable platforms for the synthesis of active pharmaceutical ingredients…

FDA and CDC Clear the Smoke on Delta-8-THC

Prohibition provides opportunities for not only black market but also unregulated market spaces. The DEA prohibits the possession, distribution, and use of delta-9-THC only, which has birthed a thriving cannabinoid market for delta-8-THC.…

The Cannabis Patent Space is Filling Quickly But These Areas are Falling Behind

The cannabis industry is moving quickly as more states hop on board with medical and recreational cannabis, leaving behind the days of prohibition. In just the last 5 years, there has been a 374% increase in patent asset publishings. Some…

ScottsMiracle-Gro Purchases Rhizoflora for its Patent Assets

Shortly after ScottsMiracle-Gro announced its cannabis investing plans, it announced it would be acquiring the Terpinator® and Purpinator® brands owned by Rhizoflora. What sets Rhizoflora apart from its competitors? Patent assets.  Even if…

Smart Cannabis Dosing through Meta Analysis

One of the biggest drawbacks to medicinal cannabis use is knowing how much to use. Do you take one puff, two, or smoke until you’re married to your furniture with your thoughts heading into the abyss? That’s what many studies seek to…

Is AYR Wellness Making the Right Choice Going with Levia?

News surfaced mid-August 2021 that AYR Wellness would acquire Cultivauna, maker of the cannabis-infused spirit Levia. Levia is Massachusetts’ first cannabis beverage brand and is sold only in Massachusetts, as of August 2021. AYR Wellness,…

Latest Cannabis Patent Infringement Lawsuit – Who Could Be Next?

In what was supposed to be a pivotal case in cannabis, the United Cannabis v. Pure Hemp Collective patent litigation was brought to a less than desired ending when UCANN announced bankruptcy and sitting Judge William J. Martinez closed the…

Scotts Miracle-Gro Invests $150 Million to Pursue New Areas in Cannabis for Subsidiary – Patent Forecast Can Do Just That!

Scotts Miracle-Gro (SMG) has had a part in the cannabis industry since 2014 through its subsidiary Hawthorne Gardening Company who specializes in cannabis gardening and hydroponics. In August 2021, SMG announced its cannabis investment…

Were You Exposed to COVID-19? Here’s What You Could Do Next.

Note: This article is not intended as medical advice.  The COVID-19 pandemic has inspired people of all talents to help wherever they can whether it be distilling hand sanitizer rather than spirits or making masks rather than shirts. Most…

Cannabis Crickets Might be the Key to Expanding Human Life to Mars

Worldwide, high profile billionaires are pouring money into the space race. According to Euroconsult’s Government Space Programs 2019 report, $70.9 billion was spent on government space programs around the world in 2018. Elon Musk’s…

Patents Suggest Cancer Treatments are Next for GW Pharmaceuticals After Epilepsy

GW Pharmaceuticals, purchased by Jazz Pharmaceuticals in May of 2021, has brought the cannabis spotlight onto itself, firstly by creating the largest cannabis-related patent portfolio and secondly by receiving the first FDA approval for a…

GW Pharmaceuticals’ Patent Assets Cover Treating Cancer with Cannabinoids

GW Pharmaceuticals has done a great job keeping everyone in the cannabis industry on their toes from its FDA drug approval to its recent acquisition by Jazz Pharmaceuticals. The latest buzz to come from GW is its recently granted patent…

Cannabis Patent Trends in 2021: Big Tobacco, Big Pharma and Big Cannabis – What are they missing?

2021 has been a year to watch for cannabis. Big Tobacco is heavily interested in the industry - acquiring companies, lobbying, and investing in IP. Big Pharma is just as anticipatory of the industry and is busy securing IP and acquiring…

First True THCV Cultivars Patented by GenCann, LLC

GenCann, LLC, previously highlighted by Patent Forecast® in October 2020, was just granted three patents (its first patents to be granted) on June 29, 2021 for its primarily THCV cultivar cannabis plants named ‘V1’, ‘V2’, and ‘V3’. The…

Patent Forecast® gives you AI-driven, interactive data that identifies key innovators and first movers.

Includes interactive Patent Radian, real-time USPTO updates, and market insights.

TRY IT FREE FOR 7 DAYS